Overview
Autoimmune thyroiditis, including Hashimoto's thyroiditis, is characterized by immune-mediated destruction of thyroid tissue leading to hypothyroidism. It involves the production of thyroid autoantibodies and is associated with dysregulation of immune tolerance mechanisms 13.Diagnosis
Key Diagnostic Criteria: Presence of elevated thyroid peroxidase (TPO) antibodies and/or thyroglobulin antibodies, along with clinical and biochemical evidence of hypothyroidism (elevated TSH, low free T4) 15.
Recommended Tests: Serum TSH, free T4, TPO antibodies, thyroglobulin antibodies, and thyroid ultrasound 15.
Grading: Subclinical hypothyroidism can be diagnosed with elevated TSH alone; overt hypothyroidism requires low free T4 5.Management
First-Line Treatments: Levothyroxine replacement therapy to normalize TSH levels 15.
Adjunctive Treatments:
- Vitamin D Supplementation: Consider in patients with vitamin D deficiency to potentially reduce autoantibody titers and modulate immune response 145.
- Monitoring: Regular follow-up to adjust levothyroxine dose and monitor thyroid function and antibody levels 15.Special Populations
Pediatrics: Vitamin D deficiency is prevalent; supplementation may enhance regulatory T cell function and reduce autoimmune activity 45.
Elderly: Increased risk of vitamin D deficiency; monitoring and supplementation may be beneficial 15.
Comorbidities: No specific recommendations noted for comorbidities like panic disorder, though autoimmune thyroiditis does not commonly associate with increased prevalence of antithyroid antibodies in these cases 6.Key Recommendations
Screen for and treat vitamin D deficiency in patients with autoimmune thyroiditis to potentially modulate immune response and reduce autoantibody levels (Evidence: Moderate 145).
Initiate levothyroxine therapy to normalize TSH levels in patients diagnosed with overt hypothyroidism due to autoimmune thyroiditis (Evidence: Strong 15).
Regularly monitor thyroid function and autoantibody levels in patients with autoimmune thyroiditis to guide treatment adjustments (Evidence: Moderate 15).References
1 Durá-Travé T, Gallinas-Victoriano F. Autoimmune Thyroiditis and Vitamin D. International journal of molecular sciences 2024. link
2 McGwin G, Owsley C, Vicinanzo MG. Teprotumumab-Related Hearing Loss: A Large-Scale Analysis and Review of Voluntarily Reported Patient Complaints to the Food and Drug Administration (FDA). Ophthalmic plastic and reconstructive surgery 2024. link
3 Duntas LH, Alexandraki KI. On the Centennial of Vitamin D-Vitamin D, Inflammation, and Autoimmune Thyroiditis: A Web of Links and Implications. Nutrients 2022. link
4 Şıklar Z, Karataş D, Doğu F, Hacıhamdioğlu B, İkincioğulları A, Berberoğlu M. Regulatory T Cells and Vitamin D Status in Children with Chronic Autoimmune Thyroiditis. Journal of clinical research in pediatric endocrinology 2016. link
5 Metwalley KA, Farghaly HS, Sherief T, Hussein A. Vitamin D status in children and adolescents with autoimmune thyroiditis. Journal of endocrinological investigation 2016. link
6 Stein MB, Uhde TW. Autoimmune thyroiditis and panic disorder. The American journal of psychiatry 1989. link
7 Blumenthal HT, Perlstein IB. The aging thyroid. II. An immunocytochemical analysis of the age-associated lesions. Journal of the American Geriatrics Society 1987. link
8 Weigle WO. Inhibition of the production of autoimmune thyroiditis in the rabbit. Immunology 1967. link